Overview

A Study for the Treatment of Painful Diabetic Neuropathy

Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine if duloxetine can help patients with painful diabetic neuropathy.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Duloxetine Hydrochloride